“The success of each of these trials will provide meaningful insights into the value of SDM during recruitment to difficult randomized trials,” Dr Berman and colleagues noted.1
Radiation oncology will become more “highly specialized and based on integrating the whole person and his or her molecular fingerprint,” including facets of the patient that only he or she can communicate to the cancer care team, predicted Dr Berman’s team.
1. Berman AT, Rosenthal SA, Moghanaki D, Woodhouse KD, Movsas B, Vapiwala N. Focusing on the “person” in personalized medicine: the future of patient-centered care in radiation oncology. J Am Coll Radiol. 2016;13(12ptB):1571-1578.
2. Fredrichs W, Hahlweg P, Müller E, Adis C, Scholl I. Shared decision-making in oncology — a qualitative analysis of healthcare providers’ views on current practice. PLoS One. 2016;11(3):e0149789.
3. Savelberg W, Moser A, Smidt M, Boersma L, Haekens C, van der Weijden T. Protocol for a pre-implementation and post-implementation study on shared decision-making in the surgical treatment of women with early-stage breast cancer. BMJ Open. 2015;5(3):e007698.
4. Brown R, Butow P, Juraskova I, et al. Sharing decisions in breast cancer care: development of the Decision Analysis System for Oncology (DAS-O) to identify shared decision making during treatment consultations. Health Expect. 2011;14(1):29-37.